Advertisement
Singapore markets open in 3 hours 22 minutes

  • Straits Times Index

    3,367.90
    +29.33 (+0.88%)
     

  • S&P 500

    5,509.01
    +33.92 (+0.62%)
     

  • Dow

    39,331.85
    +162.33 (+0.41%)
     

  • Nasdaq

    18,028.76
    +149.46 (+0.84%)
     

  • Bitcoin USD

    61,904.32
    -1,140.06 (-1.81%)
     

  • CMC Crypto 200

    1,332.23
    -12.28 (-0.91%)
     

  • FTSE 100

    8,121.20
    -45.56 (-0.56%)
     

  • Gold

    2,338.60
    -0.30 (-0.01%)
     

  • Crude Oil

    83.17
    -0.21 (-0.25%)
     

  • 10-Yr Bond

    4.4360
    -0.0430 (-0.96%)
     

  • Nikkei

    40,074.69
    +443.63 (+1.12%)
     

  • Hang Seng

    17,769.14
    +50.53 (+0.29%)
     

  • FTSE Bursa Malaysia

    1,597.96
    -0.24 (-0.02%)
     

  • Jakarta Composite Index

    7,125.14
    -7,139.63 (-50.05%)
     

  • PSE Index

    6,358.96
    -39.81 (-0.62%)
     

EU antitrust regulators set Nov. 28 deadline for Novozymes, Chr. Hansen deal

Reuters
·1-min read
FILE PHOTO: A worker for the Danish biopharmaceutical company Novozymes stands next to fermentation vates for producing enzymes at a factory in Beijing

BRUSSELS (Reuters) - EU antitrust regulators will decide by Nov. 28 whether to clear Danish food ingredients and enzymes makers Novozymes and Chr. Hansen's tie-up, according to a European Commission filing.

The companies, which announced the deal in December last year, sought EU approval for the merger last Friday.

The EU competition enforcer can decide to clear the deal with or without remedies after its preliminary review or it can open a four-month long investigation if it has serious concerns.

Chr. Hansen focuses on enzymes and microbials for the food sector, while Novozymes' largest business areas include enzymes for household products, food and beverages and biofuels.

(Reporting by Foo Yun Chee; editing by Barbara Lewis)